[1] Gustafsson BI, Kidd M, Chan A, et al.  Bronchopulmonary neuroendocrine tumors[J]. Cancer, 2008, 113(1): 5-21.   doi: 10.1002/cncr.23542
[2] Saber M, Ismail Y, Alieldin N, et al.  Neuroendocrine tumors of the lung: a five-year retrospective experience of Egyptian NCI (2010−2014)[J]. J Egypt Natl Canc Inst, 2018, 30(4): 151-158.   doi: 10.1016/j.jnci.2018.10.005
[3] Travis WD, Brambilla E, Nicholson AG, et al.  The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification[J]. J Thorac Oncol, 2015, 10(9): 1243-1260.   doi: 10.1097/JTO.0000000000000630
[4] 刘昕, 汪世存, 倪明, 等.  18F-FDG PET/CT在肺神经内分泌肿瘤中的应用[J]. 中国医学影像学杂志, 2019, 27(5): 355-359.   doi: 10.3969/j.issn.1005-5185.2019.05.009
Liu X, Wang SC, Ni M, et al.  Application of 18F-FDG PET/CT in pulmonary neuroendocrine tumors[J]. Chin J Med Imaging, 2019, 27(5): 355-359.   doi: 10.3969/j.issn.1005-5185.2019.05.009
[5] 郭丽娟, 向颖, 王红, 等.  肺神经内分泌肿瘤不同亚型CT特征差异研究[J]. 实用放射学杂志, 2018, 34(4): 518-521.   doi: 10.3969/j.issn.1002-1671.2018.04.008
Guo LJ, Xiang Y, Wang H, et al.  Differences of CT features for different subtypes of pulmonary neuroendocrine tumors[J]. J Pract Radiol, 2018, 34(4): 518-521.   doi: 10.3969/j.issn.1002-1671.2018.04.008
[6] Dincer HE, Podgaetz E, Andrade RS.  Pulmonary neuroendocrine tumors: part I. Spectrum and characteristics of tumors[J]. J Bronchol Interv Pulmonol, 2015, 22(3): 267-273.   doi: 10.1097/LBR.0000000000000157
[7] Fink G, Krelbaum T, Yellin A, et al.  Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature[J]. Chest, 2001, 119(6): 1647-1651.   doi: 10.1378/chest.119.6.1647
[8] 曾亮, 崔文静, 崔灿, 等.  肺少见神经内分泌癌的CT表现[J]. 医学研究生学报, 2017, 30(11): 1204-1207.   doi: 10.16571/j.cnki.1008-8199.2017.11.016
Zeng L, Cui WJ, Cui C, et al.  CT findings of rare pulmonary neuroendocrine carcinoma[J]. J Med Postgrad, 2017, 30(11): 1204-1207.   doi: 10.16571/j.cnki.1008-8199.2017.11.016
[9] 李小雪, 蒲红.  CT诊断及鉴别诊断原发性肺类癌(附10例分析)[J]. 中国医学影像技术, 2020, 36(1): 142-143.
Li XX, Pu H.  CT diagnosis and differential diagnosis of primary pulmonary carcinoid (analysis of 10 cases)[J]. Chin J Med Imaging Technol, 2020, 36(1): 142-143.
[10] Yi CA, Lee KS, Kim EA, et al.  Solitary pulmonary nodules: dynamic enhanced multi-detector row CT study and comparison with vascular endothelial growth factor and microvessel density[J]. Radiology, 2004, 233(1): 191-199.   doi: 10.1148/radiol.2331031535
[11] Baine MK, Rekhtman N.  Multiple faces of pulmonary large cell neuroendocrine carcinoma: update with a focus on practical approach to diagnosis[J]. Transl Lung Cancer Res, 2020, 9(3): 860-878.   doi: 10.21037/tlcr.2020.02.13
[12] 刘莉, 吴宁.  原发性肺腺样囊性癌的CT表现[J]. 中国医学影像技术, 2009, 25(9): 1588-1590.
Liu L, Wu N.  CT manifestations of primary pulmonary adenoid cystic carcinoma[J]. Chinese J Med Imaging Technol, 2009, 25(9): 1588-1590.
[13] Paci M, Cavazza A, Annessi V, et al.  Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study[J]. Ann Thorac Surg, 2004, 77(4): 1163-1167.   doi: 10.1016/j.athoracsur.2003.09.070
[14] Li XC, Zhang WD, Wu XM, et al.  Mucoepidermoid carcinoma of the lung: common findings and unusual appearances on CT[J]. Clin Imaging, 2012, 36(1): 8-13.   doi: 10.1016/j.clinimag.2011.03.003
[15] 英天舒, 张伟, 崔国元, 等.  小细胞肺癌的CT影像特征及相关临床研究[J]. 医学与哲学, 2016, 37(8): 37-39.   doi: 10.12014/j.issn.1002-0772.2016.04b.13
Ying TS, Zhang W, Cui GY, et al.  CT imaging characteristics and related studies of small cell lung cancer[J]. Med Philos, 2016, 37(8): 37-39.   doi: 10.12014/j.issn.1002-0772.2016.04b.13
[16] Carter BW, Glisson BS, Truong MT, et al.  Small cell lung carcinoma: staging, imaging, and treatment considerations[J]. Radiographics, 2014, 34(6): 1707-1721.   doi: 10.1148/rg.346140178
[17] 贺锋, 陈林, 葛雨曦, 等.  小细胞肺癌的临床CT病理特点及其征象分析[J]. 中国CT和MRI杂志, 2016, 14(12): 64-67.   doi: 10.3969/j.issn.1672-5131.2016.12.022
He F, Chen L, Ge YX, et al.  Clinical CT pathological characteristics and signs of small cell lung cancer[J]. Chin J CT MRI, 2016, 14(12): 64-67.   doi: 10.3969/j.issn.1672-5131.2016.12.022
[18] Kaira K, Murakami H, Endo M, et al.  Biological correlation of 18F-FDG uptake on PET in pulmonary neuroendocrine tumors[J]. Anticancer Res, 2013, 33(10): 4219-4228.
[19] 赵承勇, 邓小毅, 王洪松, 等.  单发肺类癌的18F-FDG PET/CT表现[J]. 国际放射医学核医学杂志, 2020, 44(1): 32-36.   doi: 10.3760/cma.j.issn.1673-4114.2020.01.008
Zhao CY, Deng XY, Wang HS, et al.  18F-FDG PET/CT image manifestations of solitary lung carcinoid tumor[J]. Int J Radiat Med Nucl Med, 2020, 44(1): 32-36.   doi: 10.3760/cma.j.issn.1673-4114.2020.01.008
[20] 何巍, 穆晓东.  18F-FDG PET/CT在非小细胞肺癌肺神经内分泌肿瘤诊断中的价值[J]. 中国临床医学影像杂志, 2019, 30(10): 690-693, 707.   doi: 10.12117/jccmi.2019.10.002
He W, Mu XD.  Diagnostic value of 18F-FDG PET/CT in non-small cell lung cancer pulmonary neuroendocrine tumors[J]. J China Clin Med Imaging, 2019, 30(10): 690-693, 707.   doi: 10.12117/jccmi.2019.10.002
[21] 柳卫, 李天女, 范磊, 等.  肺大细胞神经内分泌癌的18F-FDG PET/CT表现[J]. 国际放射医学核医学杂志, 2018, 42(6): 486-490.   doi: 10.3760/cma.j.issn.1673-4114.2018.06.002
Liu W, Li TN, Fan L, et al.  18F-FDG PET/CT manifestations of pulmonary large cell neuroendocrine carcinoma[J]. Int J Radiat Med Nucl Med, 2018, 42(6): 486-490.   doi: 10.3760/cma.j.issn.1673-4114.2018.06.002